September is National Blood Cancer Awareness Month

We are supporting Blood Cancer Awareness Month by providing these lymphoma resource links and a downloadable blood cancer awareness ribbon. Show your support by adding the red ribbon to your social media channels or emails during September.

Be Part of Blood Cancer Awareness Month

September is Blood Cancer Awareness Month

Download the Blood Cancer Awareness Ribbon

Download the red blood cancer awareness ribbon and use it in your email signature, on your Facebook page, Twitter or other social media account to show your support during September.

Download a small ribbon (30px x 49px) Download a medium ribbon (60px x 98px) Download a large ribbon (80px x 130px)

Light The Night Walks
Light The Night Walk is a fundraising campaign of The Leukemia & Lymphoma Society (LLS). These events bring together families and communities to honor blood cancer survivors, as well as those lost to the diseases, and shine a light on the importance of finding cures and providing access to treatments for blood cancer patients.
Find a Light The Night Walk near you

Make a donation to Team Seattle Genetics

Light it Red for Lymphoma
Throughout the month of September, buildings and iconic landmarks around the country Light it Red for Lymphoma to not only raise awareness of the disease, but to help provide hope to all those touched by lymphoma. Find a list of Light it Red for Lymphoma sites

Educational Conferences
The Lymphoma Research Foundation is committed to providing members of the lymphoma community with accurate, up-to-date information about the diagnosis and treatment of the disease with in-person educational conferences all around the U.S.
Find details a register now

About Lymphoma

About half of the blood cancers that occur are lymphomas, or cancers of the lymphatic system.

Hodgkin lymphoma is one of two major categories of lymphoma. It is distinguished from other types of lymphoma by the presence of one characteristic type of cell, known as the Reed-Sternberg cell. A defining attribute of the Reed-Sternberg cell is its expression of the CD30 antigen. The American Cancer Society estimates that more than 9,000 people will be diagnosed with Hodgkin lymphoma in the United States during 2014.

Non-Hodgkin lymphoma is the second major category of lymphoma and represents a diverse group of cancers that develop in the lymphatic system and are characterized by uncontrolled growth and accumulation of abnormal lymphocytes. Lymphocytes are a type of white blood cell that are responsible for defending the body against infection. The most common forms of non-Hodgkin lymphoma are follicular (slower growing subtype) and diffuse large B-cell lymphoma (faster growing subtype). According to the American Cancer Society, nearly 71,000 people are expected to be diagnosed with non-Hodgkin lymphoma in the United States during 2014.

About Leukemia

Leukemia is a type of cancer that affects the blood and bone marrow, the spongy center of bones where blood cells are formed. The disease develops when blood cells produced in the bone marrow grow out of control. The four most common types of leukemia are acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL).

Acute myeloid leukemia is a type of bone marrow cancer. The American Cancer Society estimates that nearly 19,000 cases of AML will be diagnosed in the United States during 2014, and more than 10,000 people will die from the disease.

Acute lymphoblastic leukemia (also called acute lymphocytic leukemia) is a type of blood and bone marrow cancer. The American Cancer Society estimates that more than 6,000 new cases of ALL will be diagnosed in the United States during 2014, and more than 1,400 people will die from the disease.

You are now leaving Seattle Genetics' site. Seattle Genetics does not necessarily endorse the organization associated with this link and takes no responsibility for the content contained therein. This resource link is for informational purposes only. Do you want to continue to the external site and leave

No, return to

Yes, leave